• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[核酸跨越生物屏障的递送]

[Nucleic Acid Delivery across Biological Barriers].

作者信息

Miyata Kanjiro

机构信息

Department of Materials Engineering, Graduate School of Engineering, The University of Tokyo.

出版信息

Yakugaku Zasshi. 2021;141(5):635-639. doi: 10.1248/yakushi.20-00219-2.

DOI:10.1248/yakushi.20-00219-2
PMID:33952744
Abstract

One of the current critical issues in nucleic acid delivery is the efficient mRNA delivery into target cells, directed toward clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated (Cas) genome editing. To this end, we have developed a variety of cationic polyaspartamide derivatives with varying side chain structures because they can form nanocomplexes, termed polyplexes, with mRNA through electrostatic interactions. Interestingly, the delivery functions were highly affected by the chemical structures of the polyaspartamide side chains. Therefore, we review our previous research and provide a rationale for designing polypeptides for mRNA delivery.

摘要

核酸递送当前的关键问题之一是将信使核糖核酸(mRNA)高效递送至靶细胞,用于成簇规律间隔短回文重复序列(CRISPR)和CRISPR相关蛋白(Cas)介导的基因组编辑。为此,我们开发了多种具有不同侧链结构的阳离子聚天冬酰胺衍生物,因为它们可以通过静电相互作用与mRNA形成纳米复合物,即多聚体复合物。有趣的是,递送功能受到聚天冬酰胺侧链化学结构的高度影响。因此,我们回顾了之前的研究,并为设计用于mRNA递送的多肽提供了理论依据。

相似文献

1
[Nucleic Acid Delivery across Biological Barriers].[核酸跨越生物屏障的递送]
Yakugaku Zasshi. 2021;141(5):635-639. doi: 10.1248/yakushi.20-00219-2.
2
[Research advances on the development and application of clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein system].成簇规律间隔短回文重复序列(CRISPR)/CRISPR相关蛋白系统的开发与应用研究进展
Zhonghua Shao Shang Za Zhi. 2021 Jul 20;37(7):681-687. doi: 10.3760/cma.j.cn501120-20200329-00201.
3
Rational designs of in vivo CRISPR-Cas delivery systems.体内 CRISPR-Cas 递送系统的合理设计。
Adv Drug Deliv Rev. 2021 Jan;168:3-29. doi: 10.1016/j.addr.2019.11.005. Epub 2019 Nov 21.
4
[Advances in application of clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated 9 system in stem cells research].成簇规律间隔短回文重复序列(CRISPR)/CRISPR相关蛋白9系统在干细胞研究中的应用进展
Zhonghua Shao Shang Za Zhi. 2018 Apr 20;34(4):253-256. doi: 10.3760/cma.j.issn.1009-2587.2018.04.013.
5
A Toolkit of CRISPR-Based Genome Editing Systems in Drosophila.果蝇中基于CRISPR的基因组编辑系统工具包
J Genet Genomics. 2015 Apr 20;42(4):141-9. doi: 10.1016/j.jgg.2015.02.007. Epub 2015 Mar 12.
6
CRISPR/Cas: a Nobel Prize award-winning precise genome editing technology for gene therapy and crop improvement.CRISPR/Cas:一项获得诺贝尔奖的精确基因组编辑技术,可用于基因治疗和作物改良。
J Zhejiang Univ Sci B. 2021 Apr 15;22(4):253-284. doi: 10.1631/jzus.B2100009.
7
Optimisation of the clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9 : single-guide RNA (sgRNA) delivery system in a goat model.山羊模型中规律成簇间隔短回文重复序列(CRISPR)/Cas9-单向导RNA(sgRNA)递送系统的优化
Reprod Fertil Dev. 2019 Aug;31(9):1533-1537. doi: 10.1071/RD18485.
8
[Genome editing in plants directed by CRISPR/Cas ribonucleoprotein complexes].[由CRISPR/Cas核糖核蛋白复合体介导的植物基因组编辑]
Yi Chuan. 2020 Jun 20;42(6):556-564. doi: 10.16288/j.yczz.20-017.
9
[Application of clustered regularly interspaced short palindromic repeats- associated protein 9 gene editing technology for treatment of HBV infection].[成簇规律间隔短回文重复序列相关蛋白9基因编辑技术在治疗乙型肝炎病毒感染中的应用]
Zhonghua Gan Zang Bing Za Zhi. 2018 Nov 20;26(11):860-864. doi: 10.3760/cma.j.issn.1007-3418.2018.11.012.
10
Genome editing: The efficient tool CRISPR-Cpf1.基因组编辑:高效工具CRISPR-Cpf1
Nat Plants. 2017 Mar 3;3:17028. doi: 10.1038/nplants.2017.28.

引用本文的文献

1
Oral delivery of RNAi for cancer therapy.癌症治疗的 RNAi 口服递送。
Cancer Metastasis Rev. 2023 Sep;42(3):699-724. doi: 10.1007/s10555-023-10099-x. Epub 2023 Mar 27.